Related Experiment Video
Updated: Jul 9, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Are pleiotropic effects of statins real?
Alberto Corsini1, Nicola Ferri, Michele Cortellaro
1Department of Pharmacological Sciences, Luigi Sacco University of Milan, Milano, Italy. alberto.corsini@unimi.it
Vascular Health and Risk Management
|December 15, 2007
Summary
Statins offer early atheroprotective effects through mevalonic acid (MVA) pathway inhibition, independent of cholesterol reduction. These pleiotropic benefits, observed within hours, highlight statins' anti-inflammatory properties for acute conditions.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiology
Background:
- Statins' clinical benefits are linked to LDL-C reduction.
- 3-hydroxy-3-methyl-3-glutaryl coenzyme A (HMG-CoA) reductase inhibition affects cholesterol and nonsteroidal isoprenoid synthesis.
- Pleiotropic effects of statins may be independent of cholesterol lowering.
Purpose of the Study:
- To investigate the early, non-cholesterol-lowering mechanisms of statin atheroprotection.
- To differentiate pleiotropic effects from LDL-C lowering effects in early statin treatment.
- To explore the clinical relevance of early statin benefits in acute coronary syndromes.
Main Methods:
- Analysis of plasma mevalonic acid (MVA) levels post-statin initiation.
- Monitoring of low-density lipoprotein-cholesterol (LDL-C) reduction over time.
- Comparison of the time course of MVA and LDL-C changes.
Main Results:
- Plasma MVA levels decrease by up to 70% within 1-2 hours of statin treatment.
- LDL-C reduction is detectable after 24 hours and significant after 6-7 days.
- Early MVA deprivation, not LDL-C lowering, may mediate initial atheroprotective effects.
Conclusions:
- The inhibition of MVA synthesis is a key early mechanism for statin's atheroprotective effects.
- Pleiotropic, anti-inflammatory effects of statins are clinically important in the early phase of treatment.
- Acute coronary syndromes may benefit from early statin therapy within 24 hours, irrespective of LDL-C reduction.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...